Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

New England Journal of Medicine

Volumn 359, Issue 24, 2008, Pages 2533-2544

  Abdulla, Salim ^a   Oberholzer, Rolf ^a,b   Juma, Omar ^a   Kubhoja, Sulende ^c   Machera, Francisca ^a   Membi, Christopher ^a   Omari, Said ^a   Urassa, Alwisa ^a   Mshinda, Hassan ^a   Jumanne, Ajuza ^a   Salim, Nahya ^a   Shomari, Mwanjaa ^a   Aebi, Thomas ^a,b   Schellenberg, David M ^a,d   Carter, Terrell ^e   Villafana, Tonya ^e   Demoitié, Marie Ange ^f   Dubois, Marie Claude ^f   Leach, Amanda ^f   Lievens, Marc ^f   Vekemans, Johan ^f   Cohen, Joe ^f   Ballou, W Ripley ^g   Tanner, Marcel ^a,b   more..

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Program for Appropriate Technology in Health PATH Malaria Vaccine Initiative   (United States)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^g BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MALARIA VACCINE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; RTS,S AS02D VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANEMIA; ANOREXIA; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIPHTHERIA; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE SEQUENCE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GASTROENTERITIS; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH SURVEY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFLUENZA VACCINATION; IRRITABILITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PAIN; PERTUSSIS; PLASMODIUM FALCIPARUM; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SIDE EFFECT; SWELLING; TANZANIA; TETANUS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 57649123026     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0807773     Document Type: Article

References (12)

1. Roberts L, Enserink M. Malaria: did they really say . . . eradication? Science 2007;318:1544-5.
2. SADC Ministers of Health. Strategic plan to fight against malaria in the region. Gaborone, Botswana: Southern African Development Community, March 2007.
3. Stoute JA, Slaoui M, Heppner DG, et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 1997;336:86-91.
4. Kester KE, McKinney DA, Tornieporth N, et al. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis 2001;183:640-7.
5. Bojang KA, Milligan PJ, Pinder M, et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 2001;358:1927-34.
6. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004;364:1411-20.
7. Alonso PL, Sacarlal J, Aponte JJ, et al. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Lancet 2005;366:2012-8.
8. Snow RW, Bastos de Azevedo I, Lowe BS, et al. Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. Acta Trop 1994;57:289-300.
9. Immunization summary: the 2007 edition. Geneva: UNICEF, World Health Organization, 2007.
10. Aponte JJ, Aide P, Renom M, et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007;370:1543-51.
11. Macete EV, Sacarlal J, Aponte JJ, et al. Evaluation of two formulations of adjuvanted RTS,S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a phase I/IIb randomized double-blind bridging trial. Trials 2007;8:11.
12. Saute F, Aponte J, Almeda J, et al. Malaria in southern Mozambique: malariometric indicators and malaria case definition in Manhiça district. Trans R Soc Trop Med Hyg 2003;97:661-6.